17-44354533-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_198475.3(FAM171A2):​c.1681G>A​(p.Glu561Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,173,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E561G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000047 ( 0 hom. )

Consequence

FAM171A2
NM_198475.3 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.29

Publications

0 publications found
Variant links:
Genes affected
FAM171A2 (HGNC:30480): (family with sequence similarity 171 member A2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25323224).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM171A2NM_198475.3 linkc.1681G>A p.Glu561Lys missense_variant Exon 8 of 8 ENST00000293443.12 NP_940877.2 A8MVW0
FAM171A2XM_017024490.2 linkc.1129G>A p.Glu377Lys missense_variant Exon 6 of 6 XP_016879979.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM171A2ENST00000293443.12 linkc.1681G>A p.Glu561Lys missense_variant Exon 8 of 8 1 NM_198475.3 ENSP00000293443.6 A8MVW0

Frequencies

GnomAD3 genomes
AF:
0.0000338
AC:
5
AN:
148024
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000732
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000109
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000468
AC:
48
AN:
1025426
Hom.:
0
Cov.:
31
AF XY:
0.0000558
AC XY:
27
AN XY:
483786
show subpopulations
African (AFR)
AF:
0.000193
AC:
4
AN:
20738
American (AMR)
AF:
0.00
AC:
0
AN:
6708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11546
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21786
South Asian (SAS)
AF:
0.00
AC:
0
AN:
19070
European-Finnish (FIN)
AF:
0.000154
AC:
3
AN:
19456
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2588
European-Non Finnish (NFE)
AF:
0.0000441
AC:
39
AN:
883928
Other (OTH)
AF:
0.0000505
AC:
2
AN:
39606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000338
AC:
5
AN:
148024
Hom.:
0
Cov.:
32
AF XY:
0.0000555
AC XY:
4
AN XY:
72094
show subpopulations
African (AFR)
AF:
0.0000732
AC:
3
AN:
40978
American (AMR)
AF:
0.00
AC:
0
AN:
14936
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3398
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5050
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000109
AC:
1
AN:
9150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.0000151
AC:
1
AN:
66438
Other (OTH)
AF:
0.00
AC:
0
AN:
2036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 25, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1681G>A (p.E561K) alteration is located in exon 8 (coding exon 8) of the FAM171A2 gene. This alteration results from a G to A substitution at nucleotide position 1681, causing the glutamic acid (E) at amino acid position 561 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0049
T
Eigen
Benign
0.036
Eigen_PC
Benign
-0.091
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.67
T
M_CAP
Pathogenic
0.68
D
MetaRNN
Benign
0.25
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.97
L
PhyloP100
1.3
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.045
Sift
Benign
0.24
T
Sift4G
Benign
0.46
T
Polyphen
1.0
D
Vest4
0.10
MutPred
0.35
Gain of ubiquitination at E561 (P = 0.0031);
MVP
0.095
ClinPred
0.70
D
GERP RS
3.1
Varity_R
0.18
gMVP
0.37
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1213018336; hg19: chr17-42431901; API